Recce Pharmaceuticals Ltd
RECEF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,449 | $4,415 | $1,562 | $11,582 |
| Short-Term Investments | $237 | $0 | $0 | $0 |
| Receivables | $435 | $159 | $91 | $583 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $208 | $340 | $160 | $20 |
| Total Curr. Assets | $11,386 | $5,136 | $1,947 | $12,185 |
| Property Plant & Equip (Net) | $1,028 | $1,233 | $608 | $439 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | -$0 | -$0 |
| Total NC Assets | $1,028 | $1,233 | $608 | $439 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,414 | $6,370 | $2,556 | $12,624 |
| Liabilities | – | – | – | – |
| Payables | $2,183 | $3,967 | $949 | $481 |
| Short-Term Debt | $1,527 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,410 | $10,309 | $3,343 | $1,515 |
| Total Curr. Liab. | $6,129 | $15,070 | $4,850 | $2,447 |
| LT Debt | $8,599 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $319 | $237 | $192 | $115 |
| Total NC Liab. | $9,337 | $824 | $295 | $115 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $643 | $811 | $103 | $75 |
| Total Liabilities | $15,467 | $15,893 | $5,145 | $2,562 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $81,502 | $54,839 | $44,112 | $43,968 |
| Retained Earnings | -$91,504 | -$70,076 | -$55,535 | -$42,458 |
| AOCI | $6,950 | $5,713 | $8,835 | $8,551 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$3,052 | -$9,524 | -$2,589 | $10,061 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,414 | $6,370 | $2,556 | $12,624 |
| Net Debt | -$324 | -$4,415 | -$1,562 | -$11,582 |